Rheumatologic diseases in the intensive care unit: epidemiology, clinical approach, management, and outcome.
about
[Outcome of intensive medical care for inflammatory rheumatic diseases].Prognosis and ICU outcome of systemic vasculitisChemiluminescent immunoassay technology: what does it change in autoantibody detection?Detection of autoantibodies in a point-of-care rheumatology setting.Spontaneous esophageal perforation in a patient with mixed connective tissue diseaseAutoimmune rheumatic diseases in the intensive care unit: experience from a tertiary referral hospital and review of the literature.Outcome of patients with autoimmune diseases in the intensive care unit: a mixed cluster analysis.Pulmonary vasculitis in the intensive care unit.Connective Tissue Disease-Associated Interstitial Lung Disease: A Focused Review.Outcome of patients with systemic diseases admitted to the medical intensive care unit of a tertiary referral hospital: a single-centre retrospective study.Emerging technologies in autoantibody testing for rheumatic diseases.Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis.Interstitial pneumonia with autoimmune features: an additional risk factor for ARDS?Outcomes and organ dysfunctions of critically ill patients with systemic lupus erythematosus and other systemic rheumatic diseases.Clinical presentations and outcomes of systemic lupus erythematosus patients with infection admitted to the intensive care unit.Outcome of patients with connective tissue disease requiring intensive care for respiratory failure.[Rheumatology - Integration into student training (RISA) : Current structure of clinical rheumatology in German universities (RISA III)].The Accuracy of Saps Ii and Sofa Score to Predict Mortality in Immunosuppressed Patients Admitted in Intensive Care.
P2860
Q30313874-1E692BA7-D515-4EF6-B963-02EDB8E6DAD2Q33591594-028953B7-FD6A-4C3F-901D-D3A14198087EQ33830773-6CEDC3E8-3667-4DD7-AE0C-C87A66588B45Q35309576-3CB8DE88-7623-456C-A292-4789CC7FDA9CQ35687057-90829500-4603-4A2E-AE45-EDD9E5A7D2F8Q36112207-0CCE956C-B765-45E7-8949-5CEECCC739EFQ36375678-5F32D89D-2C82-4B61-BB13-2376567C0F84Q37861390-4762F537-0C94-4784-B8C4-6758D3FFB331Q38174050-2E8D0432-9132-457B-B0E8-82143DE54BB8Q38602897-54BE6A58-12D7-4A43-91DB-5823532D9FF8Q39454840-257166E7-7AEC-43EF-BEC0-BE122A2A659BQ41588352-B53896AF-C8C6-4835-8D11-3EA1A5C50710Q41681887-11462F5D-F22A-4750-8604-38E882F25E73Q43820815-AD357FC3-6E2D-43A0-A43B-ED61D553A5DDQ50853146-677295B8-37D4-4763-BAB6-95346CEAEEECQ51005926-6A301ED3-D10E-4704-8F5C-32F0C4F7B144Q52852176-A0BE2BE2-F5B1-428B-AA4D-48F5FA1ED613Q54522915-C4102C09-39FE-4A5E-A734-DAE77CA908E1
P2860
Rheumatologic diseases in the intensive care unit: epidemiology, clinical approach, management, and outcome.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Rheumatologic diseases in the ...... oach, management, and outcome.
@ast
Rheumatologic diseases in the ...... oach, management, and outcome.
@en
Rheumatologic diseases in the ...... oach, management, and outcome.
@nl
type
label
Rheumatologic diseases in the ...... oach, management, and outcome.
@ast
Rheumatologic diseases in the ...... oach, management, and outcome.
@en
Rheumatologic diseases in the ...... oach, management, and outcome.
@nl
prefLabel
Rheumatologic diseases in the ...... oach, management, and outcome.
@ast
Rheumatologic diseases in the ...... oach, management, and outcome.
@en
Rheumatologic diseases in the ...... oach, management, and outcome.
@nl
P2093
P1476
Rheumatologic diseases in the ...... oach, management, and outcome.
@en
P2093
Dilip R Karnad
Kalpalatha K Guntupalli
Namieta M Janssen
P304
P356
10.1016/S0749-0704(02)00025-8
P577
2002-10-01T00:00:00Z